Skip to main content
HairCited

Medical and procedural treatment of androgenetic alopecia - Where are we?

Nathalie Y Ly, Sophia Fruechte, Maria K Hordinsky, Neil Sadick, Suleima Arruda et al.
Review Journal of the American Academy of Dermatology 2023 20 citas
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D37591565'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Tipo de estudio
Review
Población
Patients with androgenetic alopecia
Intervención
Medical and procedural treatment of androgenetic alopecia - Where are we? LDOM, finasteride, PRP, photobiomodulation
Comparador
None
Resultado primario
AGA treatment advances overview
Dirección del efecto
Positive
Riesgo de sesgo
Unclear

Abstract

Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians' fingertips.

TL;DR

None

Used In Evidence Reviews

Similar Papers